Glycopeptide-resistant enterococci: A decade of experience

Journal of Medical Microbiology

Volumn 47, Issue 10, 1998, Pages 849-862

  Woodford, Neil ^a  

^a CENTRAL PUBLIC HEALTH LABORATORY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; AVOPARCIN; DALFOPRISTIN PLUS QUINUPRISTIN; GLYCOPEPTIDE; PEPTIDOGLYCAN; STREPTOGRAMIN; TEICOPLANIN; VANCOMYCIN; VIRGINIAMYCIN;

ANTIBIOTIC RESISTANCE; BACTERIAL GENE; BINDING AFFINITY; ENTEROCOCCUS; ENTEROCOCCUS FAECALIS; HOSPITAL INFECTION; NONHUMAN; PLASMID; PRIORITY JOURNAL; REVIEW; TRANSPOSON;

EID: 0031730313     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/00222615-47-10-849     Document Type: Review

References (126)

1. Uttley AHC, Collins CH, Naidoo J, George RC. Vancomycin-resistant enterococci. Lancet 1988; 1: 57-58.
2. Leclercq R, Derlot E, Duval J, Courvalin P. Strains of Enterococcus faecium highly resistant to vancomycin and teicoplanin. Program and Abstracts of the 27th Interscience Conference on Antimicrobial Agents and Chemotherapy 1987; 275. Abstract 1023.
3. Leclercq R, Derlot E, Duval J, Courvalin P. Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium. N Engl J Med 1988; 319: 157-161.
4. Perichon B, Reynolds P, Courvalin P. VanD-type glycopeptide-resistant Enterococcus faecium BM4339. Antimicrob Agents Chemother 1997; 41: 2016-2018.
5. Clark NC, Hill BC, Tenover FC. Characterization of an Enterococcus raffinosus isolate with a VanB phenotype and vanA genotype. Program and Abstracts of the 94th ASM General Meeting 1994; A-111.
6. Hayden MK, Picken RN, Sahm DF. Heterogeneous expression of glycopeptide resistance in enterococci associated with transfer of vanB. Antimicrob Agents Chemother 1997; 41: 872-874.
7. Hayden MK, Trenholme GM, Schultz JE, Sahm DF. In vivo development of teicoplanin resistance in a VanB Enterococcus faecium isolate. J Infect Dis 1993; 167: 1224-1227.
8. Green M, Binczewski B, Pasculle AW et al. Constitutively vancomycin-resistant Enterococcus faecium resistant to synergistic β-lactam combinations. Antimicrob Agents Chemother 1993; 37: 1238-1242.
9. Sahm DF, Free L, Handwerger S. Inducible and constitutive expression of vanC-1-encoded resistance to vancomycin in Enterococcus gallinarum. Antimicrob Agents Chemother 1995; 39: 1480-1484.
10. Arthur M, Molinas C, Depardieu F, Courvalin P. Characterization of Tn1546, a Tn3-related transposon conferring glycopeptide resistance by synthesis of depsipeptide peptidoglycan precursors in Enterococcus faecium BM4147. J Bacteriol 1993; 175: 117-127.
11. Quintiliani R, Courvalin P. Characterization of Tn1547, a composite transposon flanked by IS16 and IS256-like elements, that confers vancomycin resistance in Enterococcus faecalis BM4281. Gene 1996. 172: 1-8.
12. Morrison D, Woodford N, Cookson B. Enterococci as emerging pathogens of humans. J Appl Microbiol 1997; 83 (Suppl): 89S-99S.
13. Brisson-Noel A, Dutka-Malen S, Molinas C, Leclercq R, Courvalin P. Cloning and heterospecific expression of the resistance determinant vanA encoding high-level resistance to glycopeptides in Enterococcus faecium BM4147. Antimicrob Agents Chemother 1990; 34: 924-927.
14. Noble WC, Virani Z, Cree RGA. Co-transfer of vancomycin and other resistance genes from Enterococcus faecalis NCTC 12201 to Staphylococcus aureus. FEMS Microbiol Lett 1992; 93: 195-198.
15. Fontana R, Ligozzi M, Pedrotti C, Padovani EM, Cornaglia G. Vancomycin-resistant Bacillus circulans carrying the vanA gene responsible for vancomycin resistance in enterococci. Eur J Clin Microbiol Infect Dis 1997; 16: 473-474.
16. Power EGM, Abdulla YH, Talsania HG, Spice W, Aathithan S, French GL. vanA genes in vancomycin-resistant clinical isolates of Oeskovia turbata and Arcanobacterium (Corynebacterium) haemolyticum. J Antimicrob Chemother 1995; 36: 595-606.
17. Goldstein FW, Buu-Hoi AY, Williamson R, Acar JF. A vancomycin-resistant Enterococcus faecium susceptible to teichomycin. Program and Abstracts of the 27th Interscience Conference on Antimicrobial Agents and Chemotherapy 1987; 275. Abstract 1022.
18. Williamson R, Al-Obeid S, Shlaes JH, Goldstein FW, Shlaes DM. Inducible resistance to vancomycin in Enterococcus faecium D366. J Infect Dis 1989; 159: 1095-1104.
19. Woodford N, Johnson AP, Morrison D, Chin ATL, Stephenson JR, George RC. Two distinct forms of vancomycin resistance amongst enterococci in the UK. Lancet 1990; 335: 226.
20. Quintiliani R, Evers S, Courvalin P. The vanB gene confers various levels of self-transferable resistance to vancomycin in enterococci. J Infect Dis 1993; 167: 1220-1223.
21. Poyart C, Pierre C, Quesne G, Pron B, Berche P, Trieu-Cuot P. Emergence of vancomycin resistance in the genus Streptococcus: characterization of a vanB transferable determinant in Streptococcus bovis. Antimicrob Agents Chemother 1997; 41: 24-29.
22. Vincent S, Minkler P, Bincziewski B, Etter L, Shlaes DM. Vancomycin resistance in Enterococcus gallinarum. Antimicrob Agents Chemother 1992; 36: 1392-1399.
23. Snell JJS, Brown DFJ, Perry SF, George R. Antimicrobial susceptibility testing of enterococci: results of a survey conducted by the United Kingdom National External Quality Assessment Scheme for Microbiology. J Antimicrob Chemother 1993; 32: 401-411.
24. Tenover FC, Tokars J, Swenson J, Paul S, Spitalny K, Jarvis W. Ability of clinical laboratories to detect antimicrobial agent-resistant enterococci. J Clin Microbiol 1993; 31: 1695-1699.
25. Jett B, Free L, Sahm DF. Factors influencing the Vitek gram-positive susceptibility system's detection of vanB-encoded vancomycin resistance among enterococci. J Clin Microbiol 1996; 34: 701-706.
26. Rosenberg J, Tenover FC, Wong J, Jarvis W, Vugia DJ. Are clinical laboratories in California accurately reporting vancomycin-resistant enterococci? J Clin Microbiol 1997; 35 2526-2530.
27. Woodford N, Johnson AP, Morrison D, Speller DCE. Current perspectives on glycopeptide resistance. Clin Microbiol Rev 1995; 8: 585-615.
28. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 3rd edn. Approved Standard M7-A3. Villanova, PA, National Committee for Clinical Laboratory Standards. 1993.
29. Woodford N, Jones BL, Baccus Z, Ludlam HA, Brown DFJ. Linkage of vancomycin and high-level gentamicm resistance genes on the same plasmid in a clinical isolate of Enterococcus faecalis. J Antimicrob Chemother 1995; 35: 179-184.
30. Woodford N, Morrison D, Johnson AP et al. Plasmid-mediated vanB glycopeptide resistance in enterococci. Microb Drug Resist 1995; 1: 235-240.
31. Woodford N, Morrison D, Johnson AP, Briant V, George RC, Cookson B. Application of DNA probes for rRNA and vanA genes to investigation of a nosocomial cluster of vancomycin-resistant enterococci. J Clin Microbiol 1993; 31: 653-658.
32. Dutka-Malen S, Evers S, Courvalin P. Detection of glycopeptide resistance genotypes and identification to the species level of clinically relevant enterococci by PCR. J Clin Microbiol 1995; 33: 24-27.
33. Dutka-Malen S, Evers S, Courvalin P. Detection of glycopeptide resistance genotypes and identification to the species level of clinically relevant enterococci by PCR (Erratum). J Clin Microbiol 1995; 33: 1434.
34. Woodford N, Egelton CM, Morrison D. Comparison of PCR with phenotypic methods for the speciation of enterococci. In: Horaud T, Bouvet A, Leclercq R, de Montelos H Sicard M (eds) Streptococci and the host. (Advances in experimental medicine and biology, vol 418.) New York, Plenum Publishing Corporation. 1497: 405-408.
35. Allen NE, Hobbs JN, Richardson JM, Riggin RM. Biosynthesis of modified peptidoglycan precursors by vancomycin-resistant Enterococcus faecium. FEMS Microbiol Lett 1992; 98: 109-115.
36. Arthur M, Molinas C, Bugg TDH, Wright GD, Walsh CT, Courvalin P. Evidence for in vivo incorporation of D-lactate into peptidoglycan precursors of vancomycin-resistant enterococci. Antimicrob Agents Chemother 1992; 36: 867-869.
37. Handwerger S, Pucci MJ, Volk KJ, Liu J, Lee MS. The cytoplasmic peptidoglycan precursor of vancomycin-resistant Enterococcus faecalis terminates in lactate. J Bacteriol 1992; 174: 5982-5984.
38. Billot-Klein D, Shlaes D, Bryant D, Bell D, van Heijenoort J, Gutmann L. Peptidoglycan structure of Enterococcus faecium expressing vancomycin resistance of the VanB type. Biochem J 1996; 313: 711-715.
39. Reynolds PE, Snaith HA, Maguire AJ, Dutka-Malen S, Courvalin P. Analysis of peptidoglycan precursors in vancomycin-resistant Enterococcus gallinarum BM4174. Biochem J 1994; 301: 5-8.
40. Bugg TDH, Dutka-Malen S, Arthur M, Courvalin P, Walsh CT. Identification of vancomycin resistance protein VanA as a D-alanine:D-alanine ligase of altered substrate specificity. Biochemistry 1991; 30: 2017-2021.
41. Evers S, Reynolds PE, Courvalin P. Sequence of the vanB and ddl genes encoding D-alanine:D-laclate and D-alanine:D-alanine ligases in vancomycin-resistant Enterococcus faecalis V583. Gene 1994; 140: 97-102.
42. Evers S, Sahm DF, Courvalin P. The vanB gene of vancomycin-resistant Enterococcus faecalis V583 is structurally related to genes encoding D-Ala:D-Ala ligases and glycopeptide-resistance proteins VanA and VanC. Gene 1993; 124: 143-144.
43. Dutka-Malen S, Molinas C, Arthur M, Courvalin P. Sequence of the vanC gene of Enterococcus gallinarum BM4174 encoding a D-alanine:D-alanine ligase-related protein necessary for vancomycin resistance. Gene 1992; 112: 53-58.
44. Navarro F, Courvalin P. Analysis of genes encoding D-alanine:D-alanine ligase-related enzymes in Enterococcus casseliflavus and Enterococcus flavescens. Antimicrob Agents Chemother 1994; 38: 1788-1793.
45. Uttley AHC, George RC, Naidoo J et al. High-level vancomycin-resistant enterococci causing hospital infection. Epidemiol Infect 1989; 103: 173-181.
46. Handwerger S, Skoble J. Identification of chromosomal mobile element conferring high-level vancomycin resistance in Enterococcus faecium. Antimicrob Agents Chemother 1995; 39: 2446-2453.
47. Quintiliani R, Courvalin P. Conjugal transfer of the vancomycin resistance determinant vanB between enterococci involves the movement of large genetic elements from chromosome to chromosome. FEMS Microbiol Lett 1994; 119: 359-364.
48. Arthur M, Molinas C, Dutka-Malen S, Courvalin P. Structural relationship between the vancomycin resistance protein VanH and 2-hydroxycarboxylic acid dehydrogenases. Gene 1991; 103: 133-134.
49. Bugg TDH, Wright GD, Dutka-Malen S, Arthur M, Courvalin P, Walsh CT. Molecular basis for vancomycin resistance in Enterococcus faecium BM4147: biosynthesis of a depsipeptide peptidoglycan precursor by vancomycin resistance proteins VanH and VanA. Biochemistry 1991; 30: 10408-10415.
50. B two-component regulatory system in Enterococcus faecalis V583. J Bacteriol 1996; 178: 1302-1309.
51. Reynolds PF, Depardieu F, Dutka-Malen S, Arthur M, Courvalin P. Glycopeptide resistance mediated by enterococcal transposon Tn1546 requires production of VanX for hydrolysis of D-alanyl-D-alanine. Mol Microbiol 1994; 13: 1065-1070.
52. Wright GD, Molinas C, Arthur M, Courvalin P, Walsh CT. Characterization of VanY, a DD-carboxypeptidase from vancomycin-resistant Enterococcus faecium BM4147. Antimicrob Agents Chemother 1992; 36: 1514-1518.
53. Arthur M, Depardieu F, Snaith HA, Reynolds PE, Courvalin P. Contribution of VanY D,D-carboxypeptidase to glycopeptide resistance in Enterococcus faecalis by hydrolysis of peptidoglycan precursors. Antimicrob Agents Chemother 1994; 38: 1899-1903.
54. Arthur M, Depardieu F, Molinas C, Reynolds P, Courvalin P. The vanZ gene of Tn1546 from Enterococcus faecium BM4147 confers resistance to teicoplanin. Gene 1995; 154: 87-92.
55. Nicas TI, Wu CYE, Hobbs JN, Preston DA, Allen NE. Characterization of vancomycin resistance in Enterococcus faecium and Enterococcus faecalis. Antimicrob Agents Chemother 1989; 33: 1121-1124.
56. Shlaes DM, Bouvet A, Devine C, Shlaes JH, al-Obeid S, Williamson R. Inducible, transferable resistance to vancomycin in Enterococcus faecalis A256. Antimicrob Agents Chemother 1989; 33: 198-203.
57. Arthur M, Molinas C, Courvalin P. The VanS-VanR two-component regulatory system controls synthesis of depsipeptide peptidoglycan precursors in Enterococcus faecium BM4147. J Bacteriol 1992; 174: 2582-2591.
58. Holman TR, Wu Z, Wanner BL, Walsh CT. Identification of the DNA-binding site for the phosphorylated VanR protein required for vancomycin resistance in Enterococcus faecium. Biochemistry 1994; 33: 4625-4631.
59. Arthur M, Depardieu F, Gerbaud O, Galimand M, Leclercq R, Courvalin P. The VanS sensor negatively controls VanR-mediated transcriptional activation of glycopeptide resistance genes in Tn1546 and related elements in the absence of induction. J Bacteriol 1997; 179: 97-106.
60. Handwerger S, Discotto L, Thanassi J, Pucci MJ. Insertional inactivation of a gene which controls expression of vancomycin resistance on plasmid pHKK100. FEMS Microbiol Lett 1992; 92: 11-14.
61. Baptista M, Depardieu F, Reynolds P, Courvalin P, Arthur M. Mutations leading to increased levels of resistance to glycopeptide antibiotics in VanB-type enterococci. Mol Microbiol 1997; 25: 93-105.
62. Fraimow HS, Jungkind DL, Lander DW, Delso DR, Dean JL. Urinary tract infection with an Enterococcus faecalis isolate that requires vancomycin for growth. Ann Intern Med 1994; 121: 22-26.
63. Woodford N, Johnson AP, Morrison D et al. Vancomycin-dependent enterococci in the United Kingdom. J Antimicrob Chemother 1994; 33: 1066.
64. Green M, Shlaes JH, Barbadora K, Shlaes DM. Bacteremia due to vancomycin-dependent Enterococcus faecium. Clin Infect Dis 1995; 20: 712-714.
65. Slifkin M, Weinbaum D, Cumbie R. Vancomycin-dependent Enterococcus faecium from a blood culture. Med Microbiol Lett 1995; 4: 406-413.
66. Wilks M; Farrag N, Eltringham IJ; Hayek L; Rossney AS, McConkey SJ, Keane CT. Vancomycin-dependent enterococcus. Lancet 1997; 349: 429-430 (four letters).
67. Stewart B, Hall L, Duke B, Ball D. Vancomycin-dependent enterococci: curious phenomenon or serious threat? J Antimicrob Chemother 1997; 40: 734-735.
68. Rosato A, Pierre J, Billot-Klein D, Buu-Hoi A, Gutmann L. Inducible and constitutive expression of resistance to glycopeptides and vancomycin dependence in glycopeptide-resistant Enterococcus avium. Antimicrob Agents Chemother 1995; 39: 830-833.
69. Aslangul E, Baptista M, Fantin B et al. Selection of glycopeptide-resistant mutants of Van-B-type Enterococcus faecalis BM4281 in vitro and in experimental endocarditis. J Infect Dis 1997; 175: 598-605.
70. Sifaoui F, Gutmann L. Vancomycin dependence in a VanA-producing Enterococcus avium strain with a nonsense mutation in the natural D-Ala-D-Ala ligase gene. Antimicrob Agents Chemother 1997; 41: 1409.
71. Farrag N, Eltringham I, Liddy H. Vancomycin-dependent Enterococcus faecalis. Lancet 1996; 348: 1581-1582.
72. Jett BD, Huycke MM, Gilmore MS. Virulence in enterococci. Clin Microbiol Rev 1994; 7: 462-478.
73. Johnson AP. The pathogenicity of enterococci. J Antimicrob Chemother 1994; 33: 1083-1089.
74. Morrison D, Woodford N, Cookson BD. Epidemic vancomycin-resistant Enterococcus faecium in the UK. Clin Microbiol Infect 1996; 1: 146-147.
75. Morrison D, Cooke RPD, Kaufmann ME, Cookson BD, Stephenson J. Inter-hospital spread of vancomycin-resistant Enterococcus faecium. J Hosp Infect 1997; 36: 77-78.
76. Chadwick PR, Oppenheim BA, Fox A, Woodford N, Morgenstern GR, Scarffe JH. Epidemiology of an outbreak due to glycopeptide-resistant Enterococcus faecium on a leukaemia unit. J Hosp Infect 1996; 34: 171-182.
77. Johnson AP, Uttley AHC, Woodford N, George RC. Resistance to vancomycin and teicoplanin: an emerging clinical problem. Clin Microbiol Rev 1990; 3: 280-291.
78. McDonald LC, Jarvis WR. The global impact of vancomycin-resistant enterococci. Curr Opin Infect Dis 1997; 10: 304-309.
79. Chow JW, Kuritza A, Shlaes DM, Green M, Sahm DF, Zervos MJ. Clonal spread of vancomycin-resistant Enterococcus faecium between patients in three hospitals in two states. J Clin Microbiol 1993; 31: 1609-1611.
80. Dunne WM, Wang W. Clonal dissemination and colony morphotype variation of vancomycin-resistant Enterococcus faecium isolates in Metropolitan Detroit, Michigan. J Clin Microbiol 1997; 35: 388-392.
81. Bates J, Jordens Z, Selkon JB. Evidence for an animal origin of vancomycin-resistant enterococci. Lancet 1993; 342: 490-491.
82. Bates J, Jordens JZ, Griffiths DT. Farm animals as a putative reservoir for vancomycin-resistant enterococcal infection in man. J Antimicrob Chemother 1994; 34: 507-514.
83. Torres C, Reguera JA, Sanmartin MJ, Perez-Diaz JC, Baquero F. vanA-Mediated vancomycin-resistant Enterococcus spp. in sewage. J Antimicrob Chemother 1994; 33: 553-561.
84. Aarestrup FM. Occurrence of glycopeptide resistance among Enterococcus faecium isolates from conventional and ecological poultry farms. Microb Drug Resist 1995; 1: 255-257.
85. Klare I, Heier H, Claus H et al. Enterococcus faecium strains with vanA-mediated high-level glycopeptide resistance isolated from animal foodstuffs and fecal samples of humans in the community. Microb Drug Resist 1995; 1: 265-272.
86. Klare I, Heier H, Claus H, Reissbrodt R, Witte W. vanA-mediated high-level glycopeptide resistance in Enterococcus faecium from animal husbandry. FEMS Microbiol Lett 1995; 125: 165-172.
87. Witte W, Klare I. Glycopeptide-resistant Enterococcus faecium outside hospitals: a commentary. Microb Drug Resist 1995; 1: 259-263.
88. Aarestrup FM, Ahrens P, Madsen M, Pallesen EV, Poulsen RL, Westh H. Glycopeptide susceptibility among Danish Enterococcus faecium and Enterococcus faecalis isolates of animal and human origin and PCR identification of genes within the VanA cluster. Antimicrob Agents Chemother 1996; 40: 1938-1940.
89. Chadwick PR, Woodford N, Kaczmarski EB, Gray S, Barrell RA, Oppenheim BA. Glycopeptide-resistant enterococci from uncooked meat. J Antimicrob Chemother 1996; 38: 908-909.
90. Devriese LA, Ieven M, Goossens H et al. Presence of vancomycin-resistant enterococci in farm and pet animals. Antimicrob Agents Chemother 1996; 40: 2285-2287.
91. Van der Auwera P, Pensart N, Korten V, Murray BE, Leclercq R. Influence of oral glycopeptides on the fecal flora of human volunteers: selection of highly glycopeptide-resistant enterococci. J Infect Dis 1996; 173: 1129-1136.
92. Wegener HC, Madsen M, Nielsen N, Aarestrup FM. Isolation of vancomycin resistant Enterococcus faecium from food. Int J Food Microbiol 1997; 35: 57-66.
93. Coque TM, Tomayko JF, Ricke SC, Okhyusen PC, Murray BE. Vancomycin-resistant enterococci from nosocomial, community, and animal sources in the United States. Antimicrob Agents Chemother 1996; 40: 2605-2609.
94. Dunne WMJ, Dunne BS, Smith D. Watch out where the huskies go. ASM News 1996; 62: 283.
95. Schouten MA, Voss A, Hoogkamp-Korstanje JAA. VRE and meat. Lancet 1997; 349: 1258.
96. van Belkum A, van den Braak N, Thomassen R, Verbrugh H, Endtz H. Vancomycin-resistant enterococci in cats and dogs. Lancet 1996; 348: 1038-1039.
97. Wise R. Avoparcin and animal feedstuff. Lancet 1996; 347: 1835.
98. Mudd A. Vancomycin resistance and avoparcin. Lancet 1996; 347: 1412.
99. Bager F, Madsen M, Christensen J, Aarestrup FM. Avoparcin used as a growth promoter is associated with the occurrence of vancomycin-resistant Enterococcus faecium on Danish poultry and pig farms. Proc Vet Med 1997; 31: 95-112.
100. McDonald LC, Kuehnert MJ, Tenover FC, Jarvis WR. Vancomycin-resistant enterococci outside the health-care setting: prevalence, sources, and public health implications. Emerg Infect Dis 1997; 3: 311-317.
101. van den Bogaard AE, Jensen LB, Stobberingh EE. Vancomycin-resistant enterococci in turkeys and farmers. N Engl J Med 1997; 337: 1558-1559.
102. Miele A, Bandera M, Goldstein BP. Use of primers selective for vancomycin resistance genes to determine van genotype in enterococci and to study gene organization in VanA isolates. Antimicrob Agents Chemother 1995; 39: 1772-1778.
103. Jensen LB, Ahrens P, Dons L, Jones RN, Hammerum AM, Aarestrup FM. Molecular analysis of Tn1546 in Enterococcus faecium isolated from animals and humans. J Clin Microbiol 1998 (in press).
104. Woodford N, Adebiyi AA, Palepou MI, Cookson BD. Diversity of VanA glycopeptide resistance elements in enterococci from human and non-human sources. Antimicrob Agents Chemother 1998; 42: 502-508.
105. Handwerger S, Skoble J, Discotto LF, Pucci MJ. Heterogeneity of the vanA gene cluster in clinical isolates of enterococci from the Northeastern United States. Antimicrob Agents Chemother 1995; 39: 362-368.
106. Mackinnon MG, Drebot MA, Tyrell GJ. Identification and characterization of IS1476, an insertion sequence-like element that disrupts VanY function in a vancomycin-resistant Enterococcus faecium strain. Antimicrob Agents Chemother 1997; 41: 1805-1807.
107. Woodford N, Watson AP, Chadwick PR. Investigation by long PCR of the genetic elements mediating VanA glycopeptide resistance in enterococci from uncooked meat in South Manchester. In: Horaud T, Bouvet A, Leclercq R, de Montelos H, Sicar M. (eds) Streptococci and the host. Plenum, (Advances in experimental medicine and biology, vol 418.) New York. 1997: 409-412.
108. Woodford N, Stigter JM. Molecular investigation of glycopeptide resistance in gram-positive bacteria. In: Woodford N, Johnson AP (eds) Molecular bacteriology: protocols and clinical applications. Humana Press, Totowa, NJ. 1998: 579-615.
109. Dutka-Malen S, Molinas C, Arthur M, Courvalin P. The VANA glycopeptide resistance protein is related to D-alanyl-D-alanine ligase cell wall biosynthesis enzymes. Mol Gen Genet 1990; 224: 364-372.
110. Dutka-Malen S, Leclercq R, Coutant V, Duval J, Courvalin P. Phenolypic and genotypic heterogeneity of glycopeptide resistance determinants in gram-positive bacteria. Antimicrob Agents Chemother 1990; 34: 1875-1879.
111. Sosio M, Lorenzetti R, Robbiati F, Denaro M. Nucleotide sequence to a teicoplanin resistance gene from Actinoplanes teichomyceticus. Biochem Biophys Acta 1991; 1089: 401-403.
112. Billot-Klein D, Gutmann L, Sable S, Guittet E, van Heijenoort J. Modification of peptidoglycan precursors is a common feature of the low-level vancomycin-resistant VANB-type Enterococcus faecium D366 and of the naturally glycopeptide-resistant species Lactobacillus casei, Pediococcus pentosaceus, Leuconostoc mesenteroides, and Enterococcus gallinarum. J Bacteriol 1994; 176: 2398-2405.
113. Elisha BG, Courvalin P. Analysis of genes encoding D-alanine:D-alanine ligase-relaled enzymes in Leuconostoc mesenteroides and Lactobacillus spp. Gene 1995; 152: 79-83.
114. Handwerger S, Pucci MJ, Volk KJ, Liu J, Lee MS. Vancomycin-resistant Leuconostoc mesenteroides and Lactobacillus casei synthesize cytoplasmic peptidoglycan precursors that terminate in lactate. J Bacteriol 1994; 176: 260-264.
115. Evers S, Casadewall B, Charles M, Dutka-Malen S, Galimand M, Courvalin P. Evolution of structure and substrate specificity in D-alanine:D-alanine ligases and related enzymes. J Mol Evol 1996; 42: 706-712.
116. Marshall CG, Broadhead G, Leskiw BK, Wright GD. D-AlaD-ala ligases from glycopeptide antibiotic-producing organisms are highly homologous to the enterococcal vancomycin-resistance ligases VanA and VanB. Proc Natl Acad Sci USA 1997; 94: 6480-6483.
117. Moellering RC. The enterococcus: a classic example of the impact of antimicrobial resistance on therapeutic options. J Antimicrob Chemother 1991; 28: 1-12.
118. Murray BE. The life and times of the Enterococcus. Clin Microbiol Rev 1990; 3: 46-65.
119. Michel M, Gutmann L. Methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: therapeutic realities and possibilities. Lancet 1997; 349: 1901-1906.
120. Fantin H, Leclercq R, Arthur M, Duval J, Carbon C. Influence of low-level resistance to vancomycin on efficacy of teicoplanin and vancomycin for treatment of experimental endocarditis due to Enterococcus faecium. Antimicrob Agents Chemother 1991; 35: 1570-1575.
121. Nicas TI, Zeckel MK, Braun DK. Beyond vancomycin: new therapies to meet the challenge of glycopeptide resistance. Trends Microbiol 1997; 5: 240-249.
122. Woodford N, Palepou M-F, Johnson AP, Chadwick PR, Bates J. Methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci. Lancet 1997; 350: 738.
123. Hiramatsu K, Hanaki H, Ino T, Yabuta K, Oguri T, Tenover FC. Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. J Antimicrob Chemother 1997; 40: 135-136.
124. Martin R, Wilcox KR. Staphyloccoccus aureus with reduced susceptibility to vancomycin United States, 1997. MMWR 1997; 46: 765-766.
125. Anonymous. Detecting vancomycin intermediate Staphylococcus aureus. CDR Weekly 1997; 7: 417-420.
126. Boyle-Vavra S, de Jonge BLM, Ebert CC, Daum RS. Cloning of the Staphylococcus aureus ddh gene encoding NAD - dependent S-lactate dehydrogenase and insertional inactivation in a glycopeptide-resistant isolate. J Bacteriol 1997; 179: 6756-6763.